Squadron Capital Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Squadron Capital Management's TNGX Position: Q3 2026 in Review
Squadron Capital Management opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 150,000 shares worth $3.74M. The stake represents 0.94% of the portfolio and ranks #31 among its holdings.
257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Squadron Capital Management held 150,000 shares of Tango Therapeutics worth $3.74M as of Q3 2026.
- Tango Therapeutics was a new Squadron Capital Management position in Q3 2026.
- Tango Therapeutics made up 0.94% of Squadron Capital Management's portfolio in Q3 2026, its #31 holding.
- 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Squadron Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.